Senior Citizens Home Health Care Location: 25334 5 Mile Rd, Redford, Michigan 48239 Ratings: Phone: (248) 552-0764 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Victory Home Care Location: 14999 Telegraph Rd, Redford, Michigan 48239 Ratings:NA Phone: (313) 535-3500 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Compassionate Home Health Links Location: 26000 5 Mile Rd, Suite 110, Redford, Michigan 48239 Ratings:NA Phone: (313) 255-9915 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
National Home Care Location: 25210 Five Mile Rd, Redford, Michigan 48239 Ratings: Phone: (313) 387-1571 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
New Vision Homecare Location: 26065 W Six Mile Rd, Redford, Michigan 48240 Ratings: Phone: (313) 533-7350 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Able Care Location: 24634 Five Mile Rd, Suite 16, Redford, Michigan 48239 Ratings:NA Phone: (248) 307-7689 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Homeland Home Healthcare Services Location: 25245 5 Mile Rd, Suite 8 West, Redford, Michigan 48239 Ratings:NA Phone: (734) 785-0750 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
News Archive
Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc., a pharmaceutical company focused on developing and commercializing novel pain management therapies, announced that it has submitted a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for approval to market its civamide (zucapsaicin) 0.075% cream, CIVANEX®, for the treatment of signs and symptoms of osteoarthritis of the knee.
People aged 12 to 15 in England will be offered one dose of the Pfizer/BioNTech COVID-19 vaccine, following advice from the four UK Chief Medical Officers (CMOs), the Health and Social Care Secretary has announced today (Monday 13 September).
Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd., today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market Atorvastatin and has launched the product in the U.S. market.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that an overall survival benefit would be the most influential factor for three-quarters of surveyed European oncologists in their decision to prescribe a novel agent ahead of Avastin for the treatment of breast cancer.
› Verified 6 days ago